F. Kauffmann (Villejuif, France), D. Mannino (Lexington, United States of America)
Prediction of respiratory disease mortality in a population sample is improved by expressing lung function impairment as FEV1 quotient
M. R. Miller, P. F. Ole, P. Lange, J. Vestbo (Birmingham, Manchester, United Kingdom; Aarhus, Copenhagen, Denmark)
|  |
How much do factors other than smoking explain spatial variations in COPD mortality in the UK?
A. L. Hansell, P. Aylin, N. G. Best (London, United Kingdom)
| |
Validation of causes of death among COPD patients in the UK General Practice Research Database
V. A. Kiri, J. Soriano, N. Pride, J. Vestbo (London, Manchester, United Kingdom)
| |
Respiratory symptoms and two years‘ mortality in a French elderly cohort
J. Tessier, M. Marty, C. Nejjari, C. Raherison, H. Guenard, P. Barberger-Gateau, J. Dartigues (Bordeaux, France; Fez, Morocco)
| |
High coincidence of COPD with increased mortality in an unselected group of Danish patients with acute myocardial infarction
K. Iversen, J. T. R. Wilcke, E. Kjøller (Copenhagen, Denmark)
| |
Will the population ²at risk for COPD² develop COPD?
L. Larsson, A. Lindberg, A. C. Jonsson, E. Ronmark, B. Lundback (Lulea, Stockholm, Sweden)
| |
The hospital debut of COPD patients. The "Phenotype and Course of COPD" (PAC-COPD) Study
J. Garcia-Aymerich, F. P. Gómez, J. M. Anto (Barcelona, Spain)
| |
BODE is better associated with quality of life (QoL) than GOLD: data from the INTERCOM trial
F. E. van Nooten, C. R. van Wetering, A. M. Schols, M. P. Rutten-van Mölken (Rotterdam, Veldhoven, Maastricht, Netherlands)
| |
Association between quality of life and muscle strength and body mass index in a group of COPD patients
I. Ben Bihi, M. Shamssain, M. Farrow, M. Al Sayegh, S. Nasir (Sunderland, United Kingdom; Dubai, United Arab Emirates)
| |
Airflow obstruction is associated with increased health care utilization in self-reported obstructive lung disease
R. Nielsen, P. S. Bakke, A. Johannessen, E. R. Omenaas, J. E. Askildsen, A. Gulsvik (Bergen, Norway)
| |
Issues for the construction of reference curves for spirometry
S. Chinn, D. Jarvis, on behalf of the ECRHS (London, United Kingdom)
| |
Strategy for selecting a spirometric reference population
A. Johannessen, S. Lehmann, E. R. Omenaas, P. S. Bakke, A. Gulsvik (Bergen, Norway)
| |
Estimates of the prevalence of alpha-1 antitrypsin deficiency PI*S and PI*Z alleles and the numbers at risk in Europe
B. Lara, I. Blanco, F. J. de Serres, M. Miravitlles, E. Fernandez-Bustillo (Barcelona, Asturias, Spain; Research Triangle Park, United States Of America)
| |
Alpha1-antitrypsin blood levels and lung function in the population-based SAPALDIA cohort
O. Senn, E. W. Russi, C. Schindler, M. Imboden, O. Braendli, A. von Eckardstein, U. Ackermann-Liebrich, N. M. Probst-Hensch, S. Team (Zurich, Basel, Wald, Switzerland)
| |
Biological ageing, inflammation and smoking
T. S. Nawrot, J. A. Staessen, P. Holvoet, H. Struijker-Boudier, P. Schiffers, L. M. Van Bortel, R. H. Fagard, J. Gardner, M. Kimura, A. Aviv (Leuven, Ghent, Belgium; Maastricht, Netherlands; Newark, United States Of America)
| |
Inhaled corticosteroids and adrenal insufficiency: a case-control study
K. J. Mortimer, L. J. Tata, C. J. Smith, J. West, T. W. Harrison, A. E. Tattersfield, R. B. Hubbard (Nottingham, United Kingdom)
| |
Long-term association of inhaled corticosteroids and long-acting β2-agonists with lung function decline in asthma: results from the ECRHS II
R. de Marco, A. Marcon, C. Janson, M. Bugiani, I. Cerveri, A. Corsico, D. Gislason, A. Gulsvik, I. Pin, D. Jarvis (Verona, Italy)
| |
Risk of asthma-related emergency department (ED)/hospitalization events in patients with consistent, variable or intermittent inhaled corticosteroids (ICS)
A. Fuhlbrigge, D. A. Stempel, T. McLaughlin, R. H. Stanford (Boston, Seattle, Phoenix, Research Triangle Park, United States Of America)
| |
Regular consultations with health care professionals enhance asthma treatment compliance. The results of ECRHS-II
I. Cerveri, A. Corsico, L. Cazzoletti, M. C. Zoia, S. Villani, S. Accordini, C. Janson, D. Jarvis, I. Pin, E. Pozzi, R. de Marco, on behalf of the ECRHS II Working Group for Therapy and Health Economics (Italy; Sweden; United Kingdom; France)
| |
Population surveillance in North West Adelaide: medical costs among males and females with diagnosed and undiagnosed asthma
A. W. Taylor, C. R. Chittleborough, D. H. Wilson, R. J. Adams, R. E. Ruffin (Adelaide, Australia)
| |